CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Amneal Pharmaceuticals [AMRX: NYSE]

Manoj Shah, VP, IT and Business Support

Cloud Computing for Affordable Medicines

Manoj Shah

Manoj Shah

Urge to Step into Cloud Computing


We started to look at cloud computing a few years ago out of necessity, and it has gradually evolved to become an important part of our IT strategy. When Hurricane Sandy hit our region, it forced us to evaluate our disaster recovery and backup systems. This came at a crucial time for us as the company was experiencing unprecedented growth, and we could not afford to have disruptions to our operations.


While these factors provided us the impetus to consider cloud computing, we started to see the broader benefits that cloud computing had to offer in terms of flexibility and cost savings. Being able to have instant availability of resources on demand, as our business grew, we created a more nimble operating model. Longer-term, I continue to see cloud computing (private) as an important part of our IT infrastructure and extending its applications across other parts of our operations, such as HR, drug safety, revenue management, and legal, which use cloud-based (SaaS models) applications.


As the head of IT, wearing my business hat when it comes to making IT decisions has become the norm. You hear many stories about systems failing and multi-million dollars wasted. A lot of times, the reasons point to the lack of understanding of the business. Technology is really a means to an end. Without understanding the business and the goals, technology alone will not serve any purpose.


 


Guidance for Fellow CIOs


• Plan for the Long-Term: In the competitive environment, it is always very important to look ahead to support business scalability. You don’t want to be caught in a situation where technology infrastructure was the reason that prevented your business from growing.


Without understanding the business and the goals, technology alone will not serve any purpose


• Believe in New Technology: It’s easy to get comfortable with what is working. But, with the rapid technological advancements and evolving business demands, you can’t afford to be left behind. You need to be on top of what’s out there, so you can help maintain your organization’s competitive edge. Of course, you have to always validate and test, but you should not be afraid to adopt new technology to stay ahead.


• Stay Close to your Business: Technology is an enabler of business. The best CIOs I have met are the ones who are business leaders first and IT leaders second. It is an ongoing learning experience for me, but one that I have found to be rewarding and fulfilling.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/cloud-computing-for-affordable-medicines-nwid-1024.html